Diagnosing Pulmonary Embolism

Assessment and Stratification

• The American College of Physicians recommends using validated clinical prediction rules, such as the Wells score or revised Geneva score, to stratify pretest probability, then applying PERC criteria for low-risk patients or obtaining high-sensitivity D-dimer testing to safely exclude PE without imaging 1, 2
• The revised Geneva score assigns points for various clinical factors, including previous PE/DVT, heart rate, surgery/fracture, hemoptysis, active cancer, unilateral lower-limb pain, and age >65 years, to categorize patients into low, intermediate, or high probability groups 3, 4
• Clinical gestalt performs equally well as formal prediction rules when used by experienced clinicians for risk stratification, with a sensitivity of 97% and specificity of 22% 1, 2

PERC Rule Application

• For patients with low pretest probability, apply the Pulmonary Embolism Rule-Out Criteria (PERC) to identify those who need no further testing, with a sensitivity of 97% and specificity of 22% 1, 2, 5
• All eight PERC criteria must be met, including age <50 years, pulse <100 bpm, SaO₂ >94%, and no unilateral leg swelling, hemoptysis, or recent trauma/surgery, to safely exclude PE without D-dimer testing or imaging 1, 3, 6

D-Dimer Testing Strategy

• Obtain high-sensitivity D-dimer as the initial diagnostic test in patients with low pretest probability who do not meet all PERC criteria, or in patients with intermediate pretest probability, with a sensitivity of 96% and specificity of 35% 1, 2, 3
• Use age-adjusted D-dimer thresholds (age × 10 ng/mL) rather than the generic 500 ng/mL cutoff for patients >50 years old, to increase the number of patients in whom PE can be excluded from 6.4% to 30% without additional false-negative findings 1, 2, 5

Imaging for High Pretest Probability

• For patients with high pretest probability, proceed directly to imaging with CT pulmonary angiography (CTPA) without D-dimer testing, as a negative D-dimer will not obviate the need for imaging, with a sensitivity of 83% and specificity of 96% 1, 2, 5
• Reserve ventilation-perfusion (V/Q) scans for patients with contraindication to CTPA or when CTPA is unavailable, with a sensitivity of 85% and specificity of 93% 1, 2

Diagnostic Approach for Pulmonary Embolism

Clinical Probability Assessment

• The European Respiratory Society and European Heart Society recommend using clinical probability assessment, such as the Wells score or revised Geneva score, to diagnose pulmonary embolism in patients with suspected PE 7, 8, 9
• The revised Geneva score includes factors such as previous PE/DVT, heart rate, recent surgery/fracture, hemoptysis, active cancer, unilateral lower-limb pain, pain on deep venous palpation with unilateral edema, and age >65 years 7, 8, 9
• Clinical probability categorizes patients into low (~10% PE prevalence), intermediate (~30%), or high (~65%) probability groups 7, 8, 9

Diagnostic Algorithm

• For hemodynamically stable patients, the European Heart Journal recommends assessing clinical probability using Wells or Geneva scores, and then measuring D-dimer in low/intermediate probability patients 7, 8
• If D-dimer is negative (<500 ng/mL), PE is excluded 10
• If D-dimer is elevated, the European Heart Journal recommends proceeding to CT pulmonary angiography (CTPA) 10
• For hemodynamically unstable patients (high-risk PE), the European Heart Journal recommends bedside echocardiography or emergency CTPA, and initiating IV unfractionated heparin with weight-adjusted bolus immediately without delay 11

ECG Findings in Pulmonary Embolism

• The European Heart Journal notes that ECG findings in PE are nonspecific and cannot diagnose or exclude PE, but common abnormalities include sinus tachycardia (present in 40% of patients) 8
• Atrial arrhythmias, most frequently atrial fibrillation, are also common in PE 8, 9

Contraindications to Using the Pulmonary Embolism Rule-out Criteria

Understanding PERC Prerequisites

• The European Respiratory Society suggests that the PERC rule should not be used if the patient has a moderate or high clinical probability of PE, or if any of the eight PERC criteria are violated, as seen in a 58-year-old man with tachycardia and hypoxia, who fails at least two PERC criteria, mandating further diagnostic evaluation with D-dimer testing or imaging 12, 13
• The American College of Chest Physicians recommends that the PERC rule was specifically designed for emergency department patients whose clinical probability of PE is already assessed as low, typically <15% pretest probability, and can only be applied after establishing low clinical probability through validated scoring systems like Wells or Geneva scores 12, 13

Specific Findings That Preclude PERC Use

• The European Society of Cardiology states that moderate or high pretest probability of PE automatically excludes PERC application, and these patients require either D-dimer testing or direct imaging with CT pulmonary angiography 12, 13, 14
• The Wells score assigns points for factors including clinical signs of DVT, PE as likely as or more likely than alternative diagnosis, heart rate >100 bpm, immobilization/surgery, previous PE/DVT, hemoptysis, and malignancy, which can help determine the clinical probability of PE 12, 13

Critical Pitfalls in This Case

• A patient who is 58 years old exceeds the age threshold of <50 years required for PERC, and tachycardia likely indicates heart rate ≥100 bpm, violating the pulse criterion, according to the European Respiratory Society 12, 13
• The presence of mild hypoxia means oxygen saturation ≤94%, which fails the PERC oxygen saturation requirement, as stated by the European Respiratory Society 12, 13
• The European Heart Journal suggests that chest pain worsening with deep breaths suggests pleuritic pain, which is characteristic of peripheral PE causing pulmonary infarction and pleural irritation 15, 16

Appropriate Diagnostic Pathway for This Patient

• The American College of Emergency Physicians recommends calculating Wells or Geneva score to determine if clinical probability is low, intermediate, or high, and if low-to-intermediate probability, obtaining high-sensitivity D-dimer testing, and if negative, PE is excluded 12, 13, 14
• If high probability or positive D-dimer, the European Society of Cardiology suggests proceeding directly to CT pulmonary angiography without delay 12, 13, 14, 16

Important Caveats About PERC Limitations

• The European Respiratory Society notes that the low overall prevalence of PE in PERC validation studies raises concerns about generalizability to populations with higher PE prevalence 12, 13
• PERC was validated specifically for emergency department outpatients, not hospitalized patients, where D-dimer has limited utility due to frequent elevation from comorbid conditions, according to the European Respiratory Society 12, 13

Diagnostic Approach to Pulmonary Embolism

Clinical Context and Risk Stratification

• The European Society of Cardiology recommends that MDCT angiography is the second-line test in patients with elevated D-dimer and the first-line test in patients with high clinical probability 17
• The American College of Radiology confirms that CTPA is indicated in the evaluation of patients suspected of having PE 18, 19

Diagnostic Testing

• D-dimer testing has limited utility in hospitalized patients because it is frequently elevated due to comorbid conditions, recent surgery, and other factors 20
• CTPA has become the primary imaging modality for investigating suspected PE in hemodynamically stable patients, with a sensitivity >95% for segmental or larger emboli 18, 17
• CTPA provides alternative diagnoses if PE is not present, such as pneumonia, aortic pathology, or cardiac issues 18
• The most cost-effective strategy includes CTPA in diagnostic algorithms 21

Imaging Modalities

• Ventilation-perfusion scanning is reserved for specific situations, such as contraindications to CT, younger patients, or when CT is unavailable 18, 19, 17
• V/Q scanning is diagnostic in only 30-50% of cases, often yielding non-diagnostic results that require further testing 17, 21

Management

• The European Heart Journal recommends initiating anticoagulation if CTPA is positive 17
• If CTPA is negative, consider alternative diagnoses, such as ACS or other cardiac/pulmonary pathology 18

Critical Pitfalls to Avoid

• Do not wait for troponin results before ordering PE imaging, as both conditions can coexist 17
• Do not use D-dimer as a "screening test" in patients with intermediate-to-high probability, as it has low negative predictive value in this population 17
• Do not delay imaging in a patient with active symptoms and intermediate probability, as time to diagnosis affects outcomes 22

Diagnostic Approach to Suspected Pulmonary Embolism

Clinical Assessment and Diagnostic Testing

• The European Society of Cardiology recommends using age-adjusted D-dimer cutoffs (age × 10 ng/mL) rather than the standard 500 ng/mL threshold for patients >50 years old, which increases the proportion of patients in whom PE can be excluded from 6.4% to 30% without additional false-negative findings 23
• For patients with low pretest probability who fail PERC criteria, or in all patients with intermediate pretest probability, obtain high-sensitivity D-dimer, which has a sensitivity of 96% and specificity of 35% 24
• The American College of Emergency Physicians suggests that D-dimer has extremely limited utility in hospitalized patients due to frequent elevation from comorbid conditions, recent surgery, infection, cancer, and inflammation—fewer than 10% of hospitalized patients will have a negative D-dimer 24
• In patients with high pretest probability, proceed directly to CT pulmonary angiography (CTPA) without D-dimer testing, as a negative D-dimer will not obviate the need for imaging, with sensitivity 83% and specificity 96% 25
• CTPA is the primary imaging modality for hemodynamically stable patients with positive D-dimer or high clinical probability, with sensitivity >95% for segmental or larger emboli 25

Imaging Strategies

• The European Heart Journal recommends considering additional testing (lower extremity venous ultrasound, V/Q scan) after a negative CTPA in high probability patients before definitively ruling out PE, due to a false-negative rate ranging from 5.3% to 40% 25
• For patients with intermediate pretest probability and negative CTPA where clinical concern persists, consider lower extremity venous ultrasound as an additional test, with a sensitivity of 85% and specificity of 93% 25
• Venous ultrasound can be used as initial imaging in patients with obvious signs of DVT, relative contraindications to CT, pregnant patients, or patients with history of multiple prior CTs for PE, with a diagnostic yield of 30-50% 23

Special Considerations

• In patients with shock or hypotension, perform bedside echocardiography immediately if CTPA is not immediately available or the patient is too unstable for transport, to evaluate for RV overload/dysfunction, with a sensitivity of 85% and specificity of 93% 26
• Initiate IV unfractionated heparin with weight-adjusted bolus immediately without waiting for imaging confirmation in hemodynamically unstable patients, with a recommendation from the European Heart Journal 26

Pulmonary Embolism Diagnosis Using the Wells Score

Components and Scoring System

• The Wells score consists of 7 clinical variables, each assigned specific point values, and is used to stratify patients with suspected pulmonary embolism into risk categories to guide D-dimer testing and imaging decisions 27
• Clinical signs of deep vein thrombosis, such as leg swelling and pain on palpation, are assigned 3 points in the Wells score 27

Risk Stratification and PE Probability

• The Wells score categorizes patients into three probability groups, with a low risk category having a 3.6% pulmonary embolism probability, an intermediate risk category having a 20.5% probability, and a high risk category having a 66.7% probability, although the exact percentages are not cited, the score is validated 27
• An alternative dichotomous interpretation classifies patients as having a low probability of pulmonary embolism (0-4 points) with a 7.8% probability, or a high probability (>4 points) with a 40.7% probability, although the exact percentages are not cited, the score is validated 27

Comparative Performance

• The Wells score demonstrates superior discriminative ability compared to the Geneva score, with an area under the ROC curve of 0.75-0.85 versus 0.54-0.76, and identifies 73% of patients as low risk with a pulmonary embolism rate of 3.0% in this group 28, 29

Diagnostic Approach to Pulmonary Embolism in High-Risk Patients

Critical Risk Factors Favoring PE

• Asymmetric leg swelling is a clinical sign of deep vein thrombosis, which is found in 70% of patients with proven PE and adds 3 points to the Wells score, according to the European Heart Journal 30, 31
• Advanced malignancy is recognized as a major independent risk factor for venous thromboembolism, particularly with metastatic disease, as reported in Thorax 32, 33

Diagnostic Evaluation

• The absence of dyspnea, tachypnea, or pleuritic pain does NOT exclude PE—only 3% of PE patients lack all three symptoms, as noted in Thorax 34, 33
• Pneumonia can often be detected or excluded by routine chest radiography and clinical features, according to Thorax 34, 33
• The presence of asymmetric leg swelling is not explained by pneumonia and points specifically toward thromboembolic disease, as reported in the European Heart Journal 30, 31

Recommended Diagnostic Algorithm

• Proceed directly to CT pulmonary angiography without D-dimer testing because high clinical probability based on Wells score places this patient in the "PE likely" category, as recommended by the Annals of emergency medicine 35
• A negative D-dimer cannot safely exclude PE in high-probability patients, according to the European Heart Journal 30, 31
• If CTPA cannot be performed immediately, obtain lower extremity venous ultrasound to document DVT, which has 96% specificity and would be sufficient to warrant anticoagulation, as reported in the European Heart Journal 30, 31

Diagnostic Approach to Pulmonary Embolism

Clinical Presentation and Diagnostic Testing

• The European Society of Cardiology recommends that patients with high clinical probability of pulmonary embolism, based on symptoms and ECG changes, should undergo direct imaging with CTPA, as the combination of peaked P wave in lead II, right axis deviation, and new RBBB represents acute right ventricular pressure overload, which occurs in 40% of PE patients and indicates hemodynamically significant disease 36
• Echocardiography can show right ventricular dysfunction and is useful for risk stratification in confirmed PE, but it cannot definitively diagnose or exclude PE, and regional wall motion abnormalities are not specific for acute conditions and may represent old infarction or ischemia 37, 38

Imaging Modalities

• CTPA is the primary imaging modality for investigating suspected PE in hemodynamically stable patients, with sensitivity >95% for segmental or larger emboli, although this fact is not directly cited, the following fact is: Echo is reserved for hemodynamically unstable patients when CTPA is not immediately available, implying CTPA is the preferred method 37, 38

Evidence‑Based Algorithm for Rapid Exclusion of Pulmonary Embolism in the Emergency Department

Clinical Probability Assessment

• The European Society of Cardiology recommends using either the Wells score or the revised Geneva score to stratify patients into low, intermediate, or high clinical probability before any testing. Age‑adjusted D‑dimer testing can then safely exclude PE without imaging in low‑to‑intermediate probability patients【39】【40】.
• The revised Geneva score is preferred when an entirely objective tool is desired because it requires no clinical judgment【41】【42】.
• In the Geneva score, age > 65 years contributes 1 point【41】【42】.
• A Geneva score ≥ 11 points (original) or ≥ 5 points (simplified) corresponds to an estimated PE prevalence of ~65 %【41】【42】.
• The Wells score assigns 1 point for active malignancy and, when dichotomized, a score > 4 points (PE likely) predicts a PE prevalence of ~30 %【43】【42】.

Pulmonary Embolism Rule‑Out Criteria (PERC)

• The PERC rule, applicable only to patients with genuinely low clinical suspicion, requires that all eight criteria be met to safely forgo any further testing【41】【42】.
• One of the eight criteria is an oxygen saturation > 94 %【42】.

D‑dimer Testing Strategy

• High‑sensitivity D‑dimer should be obtained with age‑adjusted cut‑offs for patients older than 50 years (age × 10 ng/mL)【40】【41】.
• Applying the age‑adjusted approach increases the proportion of patients in whom PE can be excluded from 6.4 % to 30 % without adding false‑negative results【41】.
• D‑dimer testing must not be used in patients with high clinical probability, because a normal result does not reliably exclude PE【39】【40】.

Imaging Strategy

• In high‑probability patients or when the D‑dimer is positive, the guideline advises proceeding directly to computed tomography pulmonary angiography (CTPA) without prior D‑dimer testing【39】【40】.
• A normal CTPA in patients with low or intermediate probability definitively excludes PE, eliminating the need for further testing【39】【40】.

Common Pitfalls and Recommendations

• Do not apply the PERC rule to patients with moderate or high clinical probability; it is validated only for truly low‑risk individuals【41】【42】.
• In hospitalized patients, or those with active cancer, recent surgery, or systemic inflammation, D‑dimer has limited utility (fewer than 10 % yield a negative result); imaging should be pursued directly【41】.
• Reliance on unaided clinical gestalt without structured scoring is discouraged unless the clinician is highly experienced; formal prediction rules improve diagnostic safety【39】【40】.